KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nu Skin Enterprises (NUS) Cash & Equivalents (2016 - 2025)

Nu Skin Enterprises (NUS) has disclosed Cash & Equivalents for 17 consecutive years, with $238.6 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents rose 27.69% to $238.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $238.6 million through Dec 2025, up 27.69% year-over-year, with the annual reading at $238.6 million for FY2025, 27.69% up from the prior year.
  • Cash & Equivalents hit $238.6 million in Q4 2025 for Nu Skin Enterprises, down from $251.8 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $363.9 million in Q2 2022 to a low of $186.9 million in Q4 2024.
  • Historically, Cash & Equivalents has averaged $265.3 million across 5 years, with a median of $253.9 million in 2023.
  • Biggest five-year swings in Cash & Equivalents: crashed 35.27% in 2023 and later increased 27.69% in 2025.
  • Year by year, Cash & Equivalents stood at $339.6 million in 2021, then fell by 22.05% to $264.7 million in 2022, then dropped by 3.27% to $256.1 million in 2023, then fell by 27.02% to $186.9 million in 2024, then rose by 27.69% to $238.6 million in 2025.
  • Business Quant data shows Cash & Equivalents for NUS at $238.6 million in Q4 2025, $251.8 million in Q3 2025, and $264.2 million in Q2 2025.